output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. *Parenteral Nutrition, Home [adverse effects, mortality]; 2. Abdominal Neoplasms [complications]; 3. Intestinal Obstruction [etiology, mortality, *therapy]; 4. Observational Studies as Topic; 5. Quality of Life; | Provide MESH terms for the study
Home parenteral nutrition for people with inoperable malignant bowel obstruction | You are a research assistant. Based on the question please provide appropriate answers |
1. *Communication; 2. Anxiety [prevention & control]; 3. Caregivers [*education, psychology]; 4. Empathy; 5. Health Personnel [*education, psychology]; 6. Medical Oncology [*education]; 7. Neoplasms [psychology, *therapy]; 8. Oncology Nursing [education]; 9. Professional‐Patient Relations; 10. Randomized Controlled Trials as Topic; 11. Stress, Psychological [*prevention & control]; | Provide MESH terms for the study
Communication skills training for healthcare professionals working with people who have cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal, Humanized [adverse effects, *therapeutic use]; 2. Antineoplastic Agents, Immunological [adverse effects, *therapeutic use]; 3. Antineoplastic Combined Chemotherapy Protocols [adverse effects, *therapeutic use]; 4. Carcinoma [*drug therapy, pathology]; 5. Disease Progression; 6. Docetaxel; 7. Paclitaxel [administration & dosage]; 8. Quality of Life; 9. Taxoids [administration & dosage]; 10. Urinary Bladder Neoplasms [*drug therapy, pathology]; 11. Vinblastine [administration & dosage, analogs & derivatives]; | Provide MESH terms for the study
Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*administration & dosage, adverse effects]; 2. Blood Loss, Surgical [statistics & numerical data]; 3. Blood Transfusion [statistics & numerical data]; 4. Hemorrhage [chemically induced]; 5. Heparin [*administration & dosage, adverse effects]; 6. Heparin, Low-Molecular-Weight [*administration & dosage, adverse effects]; 7. Neoplasms [mortality, *surgery]; 8. Postoperative Complications [mortality, *prevention & control]; 9. Pulmonary Embolism [prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Thrombocytopenia [prevention & control]; 12. Thrombosis [mortality, *prevention & control]; 13. Venous Thrombosis [prevention & control]; | Provide MESH terms for the study
Anticoagulation for perioperative thromboprophylaxis in people with cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [*therapeutic use]; 2. Antipyrine [*analogs & derivatives, therapeutic use]; 3. Bevacizumab [adverse effects, *therapeutic use]; 4. Brain [diagnostic imaging, *radiation effects]; 5. Brain Edema [diagnostic imaging, drug therapy, etiology]; 6. Drug Therapy, Combination; 7. Edaravone; 8. Gadolinium; 9. Non‐Randomized Controlled Trials as Topic; 10. Radiation Injuries [diagnostic imaging, etiology, *therapy]; 11. Radiosurgery [adverse effects]; 12. Radiotherapy [adverse effects]; 13. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [adverse effects, *therapeutic use]; 2. Catheter-Related Infections [epidemiology]; 3. Catheterization, Central Venous [*adverse effects]; 4. Heparin [adverse effects, therapeutic use]; 5. Heparin, Low-Molecular-Weight [adverse effects, therapeutic use]; 6. Neoplasms [mortality, *therapy]; 7. Randomized Controlled Trials as Topic; 8. Secondary Prevention [methods]; 9. Thrombocytopenia [chemically induced]; 10. Venous Thrombosis [etiology, mortality, *prevention & control]; 11. Vitamin K [antagonists & inhibitors]; | Provide MESH terms for the study
Anticoagulation for people with cancer and central venous catheters | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cryotherapy [adverse effects, methods]; 2. Cause of Death; 3. Prostatic Neoplasms [mortality, pathology, radiotherapy, *therapy]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Primary cryotherapy for localised or locally advanced prostate cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Duodenum; 2. *Stents [statistics & numerical data]; 3. Eating; 4. Gastric Outlet Obstruction [etiology, mortality, *surgery]; 5. Gastrointestinal Neoplasms [*complications]; 6. Length of Stay; 7. Palliative Care [*methods]; 8. Randomized Controlled Trials as Topic; 9. Recurrence; 10. Time Factors; | Provide MESH terms for the study
Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction | You are a research assistant. Based on the question please provide appropriate answers |
1. Breast Neoplasms [epidemiology]; 2. Early Termination of Clinical Trials; 3. Endometrial Neoplasms [*chemically induced, epidemiology, surgery]; 4. Estrogen Replacement Therapy [*adverse effects]; 5. Neoplasm Recurrence, Local [*chemically induced, epidemiology]; 6. Neoplasms, Second Primary [epidemiology]; 7. Quality of Life; | Provide MESH terms for the study
Hormone replacement therapy for women previously treated for endometrial cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Human papillomavirus 16; 2. Human papillomavirus 18; 3. Papillomavirus Infections [complications, mortality, *prevention & control]; 4. Papillomavirus Vaccines [*administration & dosage, adverse effects]; 5. Precancerous Conditions [mortality, *prevention & control, virology]; 6. Pregnancy Outcome; 7. Randomized Controlled Trials as Topic; 8. Uterine Cervical Dysplasia [mortality, *prevention & control, virology]; 9. Uterine Cervical Neoplasms [mortality, *prevention & control, virology]; 10. Vaccination; | Provide MESH terms for the study
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchial Neoplasms [mortality, radiotherapy]; 2. Combined Modality Therapy [methods]; 3. Esophageal Neoplasms [mortality, radiotherapy]; 4. Head and Neck Neoplasms [mortality, radiotherapy]; 5. Hyperbaric Oxygenation [adverse effects, *methods]; 6. Neoplasm Recurrence, Local [epidemiology]; 7. Neoplasms [mortality, *radiotherapy]; 8. *Radiation Tolerance; 9. Randomized Controlled Trials as Topic; 10. Rectal Neoplasms [mortality, radiotherapy]; 11. Time Factors; 12. Urinary Bladder Neoplasms [mortality, radiotherapy]; 13. Uterine Cervical Neoplasms [mortality, radiotherapy]; | Provide MESH terms for the study
Hyperbaric oxygenation for tumour sensitisation to radiotherapy | You are a research assistant. Based on the question please provide appropriate answers |
1. Ampulla of Vater; 2. Antimetabolites, Antineoplastic [adverse effects, *therapeutic use]; 3. Antineoplastic Combined Chemotherapy Protocols [adverse effects, *therapeutic use]; 4. Biliary Tract Neoplasms [*drug therapy, mortality, pathology]; 5. Capecitabine [administration & dosage, adverse effects]; 6. Cholangiocarcinoma [*drug therapy, mortality, pathology]; 7. Cisplatin [administration & dosage, adverse effects]; 8. Deoxycytidine [adverse effects, *analogs & derivatives, therapeutic use]; 9. Drug Combinations; 10. Gallbladder Neoplasms [drug therapy, mortality, pathology]; 11. Mitomycin [administration & dosage, adverse effects]; 12. Organoplatinum Compounds [administration & dosage, adverse effects]; 13. Oxaliplatin; 14. Oxonic Acid [administration & dosage, adverse effects]; 15. Piperidines [administration & dosage, adverse effects]; 16. Quinazolines [administration & dosage, adverse effects]; 17. Randomized Controlled Trials as Topic; 18. Tegafur [administration & dosage, adverse effects]; | Provide MESH terms for the study
Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas | You are a research assistant. Based on the question please provide appropriate answers |
1. Breast Neoplasms [mortality, *pathology, *surgery, therapy]; 2. Combined Modality Therapy [methods]; 3. Mastectomy; 4. Neoplasm Metastasis; 5. Prognosis; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Breast surgery for metastatic breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Abdominal Neoplasms [*complications]; 2. Administration, Oral; 3. *Conservative Treatment; 4. Contrast Media [*administration & dosage, adverse effects]; 5. Diatrizoate Meglumine [*administration & dosage, adverse effects]; 6. Feasibility Studies; 7. Intestinal Obstruction [*diagnostic imaging, etiology, *therapy]; 8. Length of Stay; 9. Pilot Projects; | Provide MESH terms for the study
Oral water soluble contrast for malignant bowel obstruction | You are a research assistant. Based on the question please provide appropriate answers |
1. Body Composition [drug effects]; 2. Cachexia [etiology]; 3. *Eating; 4. Ghrelin [*administration & dosage, adverse effects]; 5. Neoplasms [*complications]; | Provide MESH terms for the study
Ghrelin for the management of cachexia associated with cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anti-Inflammatory Agents, Non-Steroidal [administration & dosage, *therapeutic use]; 3. Celecoxib [therapeutic use]; 4. Cyclooxygenase 2 Inhibitors [administration & dosage, *therapeutic use]; 5. Disease Progression; 6. Induction Chemotherapy [*methods]; 7. Lactones [administration & dosage, therapeutic use]; 8. Placebos [therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Sulfonamides [administration & dosage, therapeutic use]; 11. Sulfones [administration & dosage, therapeutic use]; 12. Uterine Cervical Dysplasia [*drug therapy, pathology]; 13. Uterine Cervical Neoplasms [*drug therapy, pathology]; | Provide MESH terms for the study
Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia | You are a research assistant. Based on the question please provide appropriate answers |
1. Adjuvants, Immunologic [administration & dosage]; 2. Bone Marrow Transplantation [mortality]; 3. Case‐Control Studies; 4. Cause of Death; 5. Cohort Studies; 6. Hematologic Neoplasms [immunology, mortality]; 7. Immunocompromised Host [*immunology]; 8. Influenza Vaccines [*administration & dosage, immunology]; 9. Influenza, Human [epidemiology, immunology, *prevention & control]; 10. Neoplasms [*immunology, mortality]; 11. Observational Studies as Topic; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Influenza vaccines in immunosuppressed adults with cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Anxiety [therapy]; 2. Breast Neoplasms [psychology, *therapy]; 3. Chemotherapy, Adjuvant; 4. Depression [therapy]; 5. *Exercise; 6. Fatigue [etiology]; 7. Physical Fitness; 8. Prognosis; 9. Quality of Life; 10. Radiotherapy, Adjuvant; 11. *Resistance Training; | Provide MESH terms for the study
Physical activity for women with breast cancer after adjuvant therapy | You are a research assistant. Based on the question please provide appropriate answers |
1. Case‐Control Studies; 2. Neoplasms [*prevention & control]; 3. Observational Studies as Topic; 4. Odds Ratio; 5. Randomized Controlled Trials as Topic; 6. Selenium [*administration & dosage, adverse effects]; 7. Sex Factors; 8. Trace Elements [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Selenium for preventing cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Brain Neoplasms [mortality, *radiotherapy, secondary, *surgery]; 2. Combined Modality Therapy; 3. Cranial Irradiation [methods, mortality]; 4. Dose Fractionation, Radiation; 5. Radiation-Sensitizing Agents [therapeutic use]; 6. Radiosurgery [adverse effects, methods]; 7. Randomized Controlled Trials as Topic; 8. Survival Analysis; | Provide MESH terms for the study
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases | You are a research assistant. Based on the question please provide appropriate answers |
1. Diarrhea [etiology, prevention & control]; 2. Gastrointestinal Agents [therapeutic use]; 3. Gastrointestinal Tract [drug effects, *radiation effects]; 4. Pelvic Neoplasms [*radiotherapy]; 5. Placebo Effect; 6. Radiation Injuries [*prevention & control]; 7. Radiotherapy, Conformal [*adverse effects]; 8. Radiotherapy, Intensity-Modulated [adverse effects]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [adverse effects, *therapeutic use]; 2. Carcinoma, Non‐Small‐Cell Lung [*drug therapy, ethnology, genetics]; 3. Disease‐Free Survival; 4. Gefitinib; 5. Genes, erbB‐1; 6. Lung Neoplasms [*drug therapy, ethnology, genetics]; 7. Mutation; 8. Quality of Life; 9. Quinazolines [adverse effects, *therapeutic use]; 10. Randomized Controlled Trials as Topic; 11. Treatment Failure; | Provide MESH terms for the study
Gefitinib for advanced non‐small cell lung cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Prostatic Neoplasms; 2. Bisphosphonate‐Associated Osteonecrosis of the Jaw [epidemiology]; 3. Bone Density Conservation Agents [adverse effects, *therapeutic use]; 4. Bone Neoplasms [*drug therapy, mortality, *secondary]; 5. Diphosphonates [adverse effects, *therapeutic use]; 6. Kidney [drug effects]; 7. Nausea [chemically induced]; 8. Pain [*drug therapy, etiology]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Bisphosphonates for advanced prostate cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Postoperative Care; 2. *Re‐Irradiation [adverse effects]; 3. Breast Neoplasms [mortality, *radiotherapy, *surgery]; 4. Disease‐Free Survival; 5. Mastectomy, Segmental; 6. Neoplasm Recurrence, Local [mortality, prevention & control, radiotherapy]; 7. Neoplasm, Residual; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Tumour bed boost radiotherapy for women after breast‐conserving surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Abdominal Wound Closure Techniques; 2. *Laparotomy; 3. *Suture Techniques; 4. *Sutures; 5. Fistula [epidemiology]; 6. Incisional Hernia [epidemiology, *prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Surgical Wound Dehiscence [epidemiology]; 9. Surgical Wound Infection [epidemiology]; | Provide MESH terms for the study
Closure methods for laparotomy incisions for preventing incisional hernias and other wound complications | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Bone Density Conservation Agents [*therapeutic use]; 3. Bone Neoplasms [mortality, *prevention & control, *secondary]; 4. Breast Neoplasms [mortality, *pathology]; 5. Clodronic Acid [therapeutic use]; 6. Denosumab [therapeutic use]; 7. Diphosphonates [*therapeutic use]; 8. Imidazoles [therapeutic use]; 9. Injections, Intravenous; 10. Randomized Controlled Trials as Topic; 11. Zoledronic Acid; | Provide MESH terms for the study
Bisphosphonates and other bone agents for breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Disease‐Free Survival; 2. Endometrial Neoplasms [*surgery]; 3. Lymph Node Excision [*adverse effects, mortality]; 4. Lymphatic Metastasis; 5. Lymphedema [etiology]; 6. Lymphocele [etiology]; 7. Postoperative Complications [etiology]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Lymphadenectomy for the management of endometrial cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Brain Neoplasms [mortality, *radiotherapy, *secondary]; 2. Combined Modality Therapy [methods, mortality]; 3. Cranial Irradiation [*methods, mortality]; 4. Karnofsky Performance Status; 5. Radiosurgery [*methods, mortality]; 6. Randomized Controlled Trials as Topic; 7. Steroids [therapeutic use]; | Provide MESH terms for the study
Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases | You are a research assistant. Based on the question please provide appropriate answers |
1. *Pancreaticojejunostomy [adverse effects]; 2. Gastrostomy [*adverse effects]; 3. Length of Stay; 4. Pancreatectomy [*adverse effects]; 5. Pancreatic Fistula [*prevention & control]; 6. Pancreaticoduodenectomy [*adverse effects]; 7. Postoperative Complications [*prevention & control]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Intravesical; 2. Antibiotics, Antineoplastic [*administration & dosage]; 3. BCG Vaccine [administration & dosage]; 4. Carcinoma in Situ [*drug therapy, mortality, pathology]; 5. Carcinoma, Transitional Cell [*drug therapy, mortality, pathology]; 6. Disease Progression; 7. Electrochemotherapy [adverse effects, *methods]; 8. Mitomycin [*administration & dosage]; 9. Neoplasm Recurrence, Local; 10. Randomized Controlled Trials as Topic; 11. Time Factors; 12. Urinary Bladder Neoplasms [*drug therapy, mortality, pathology]; | Provide MESH terms for the study
Intravesical electromotive drug administration for non‐muscle invasive bladder cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Laparoscopy [adverse effects, *methods]; 2. Organ Size; 3. Prostate [pathology]; 4. Prostate‐Specific Antigen [blood]; 5. Prostatectomy [adverse effects, *methods]; 6. Prostatic Neoplasms [blood, mortality, pathology, *surgery]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Robotic Surgical Procedures [adverse effects, *methods]; 10. Sexual Behavior; 11. Urination; | Provide MESH terms for the study
Laparoscopic and robotic‐assisted versus open radical prostatectomy for the treatment of localised prostate cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*administration & dosage, adverse effects]; 2. Cause of Death; 3. Hemorrhage [chemically induced, epidemiology]; 4. Heparin [*administration & dosage, adverse effects]; 5. Heparin, Low-Molecular-Weight [administration & dosage]; 6. Neoplasms [*mortality]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Survival Analysis; 10. Time Factors; 11. Venous Thromboembolism [epidemiology, *prevention & control]; 12. Warfarin [administration & dosage]; | Provide MESH terms for the study
Parenteral anticoagulation in ambulatory patients with cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*therapeutic use]; 2. Dactinomycin [*therapeutic use]; 3. Gestational Trophoblastic Disease [epidemiology, *prevention & control]; 4. Hydatidiform Mole [*drug therapy]; 5. Incidence; 6. Methotrexate [*therapeutic use]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Consolidation Chemotherapy; 2. Adrenal Gland Neoplasms [mortality, *therapy]; 3. Antineoplastic Agents [administration & dosage, *therapeutic use]; 4. Bone Marrow Transplantation; 5. Disease‐Free Survival; 6. Hematopoietic Stem Cell Transplantation [*methods]; 7. Neuroblastoma [mortality, *therapy]; 8. Randomized Controlled Trials as Topic; 9. Selection Bias; 10. Tretinoin [administration & dosage, *therapeutic use]; | Provide MESH terms for the study
Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation | You are a research assistant. Based on the question please provide appropriate answers |
1. Anxiety [rehabilitation]; 2. Breast Neoplasms [*rehabilitation, therapy]; 3. Depression [rehabilitation]; 4. *Exercise; 5. Fatigue [rehabilitation]; 6. Home Care Services; 7. Non-Randomized Controlled Trials as Topic; 8. Patient Education as Topic [methods, *organization & administration]; 9. Prognosis; 10. *Program Evaluation; 11. *Quality of Life; 12. Randomized Controlled Trials as Topic; 13. Sleep Initiation and Maintenance Disorders [rehabilitation]; 14. Survival Rate; 15. *Survivors; | Provide MESH terms for the study
Home‐based multidimensional survivorship programmes for breast cancer survivors | You are a research assistant. Based on the question please provide appropriate answers |
1. *Chemoradiotherapy [adverse effects, mortality]; 2. *Esophagectomy [mortality]; 3. Carcinoma [mortality, pathology, surgery, therapy]; 4. Carcinoma, Squamous Cell [mortality, pathology, surgery, *therapy]; 5. Cisplatin; 6. Combined Modality Therapy [adverse effects, methods, mortality]; 7. Deglutition Disorders [therapy]; 8. Esophageal Neoplasms [mortality, pathology, surgery, *therapy]; 9. Fluorouracil [administration & dosage]; 10. Neoplasm Recurrence, Local; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [adverse effects, *therapeutic use]; 2. Brain Neoplasms [*drug therapy, mortality]; 3. Cytarabine [administration & dosage]; 4. Dacarbazine [administration & dosage, adverse effects, analogs & derivatives]; 5. Disease Progression; 6. Disease‐Free Survival; 7. Drug Administration Schedule; 8. Glioma [*drug therapy, mortality]; 9. Hydroxyurea [administration & dosage]; 10. Lomustine [*administration & dosage, adverse effects]; 11. Methylprednisolone [administration & dosage]; 12. Neoplasm Recurrence, Local [*drug therapy, mortality]; 13. Procarbazine [*administration & dosage, adverse effects]; 14. Randomized Controlled Trials as Topic; 15. Temozolomide; 16. Vincristine [administration & dosage, adverse effects]; | Provide MESH terms for the study
Procarbazine, lomustine and vincristine for recurrent high‐grade glioma | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Inflammatory Agents, Non‐Steroidal [*therapeutic use]; 2. Cancer Pain [*drug therapy]; | Provide MESH terms for the study
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for cancer‐related pain in children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics, Opioid [*therapeutic use]; 2. Cancer Pain [*drug therapy]; | Provide MESH terms for the study
Opioids for cancer‐related pain in children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. Cognition; 3. Fatigue [etiology, physiopathology, psychology, *therapy]; 4. Neoplasms [*complications, physiopathology, psychology, therapy]; 5. Palliative Care [*methods]; 6. Psychotherapy [*methods]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Social Skills; | Provide MESH terms for the study
Psychosocial interventions for fatigue during cancer treatment with palliative intent | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Analgesics, Opioid [administration & dosage]; 3. Anti‐Inflammatory Agents, Non‐Steroidal [*administration & dosage, adverse effects]; 4. Cancer Pain [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Withholding Treatment [statistics & numerical data]; | Provide MESH terms for the study
Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetaminophen [*administration & dosage]; 2. Administration, Oral; 3. Analgesics, Non‐Narcotic [*administration & dosage]; 4. Analgesics, Opioid [administration & dosage]; 5. Anti‐Inflammatory Agents, Non‐Steroidal [administration & dosage]; 6. Antidepressive Agents, Tricyclic [administration & dosage]; 7. Antipsychotic Agents [administration & dosage]; 8. Cancer Pain [*drug therapy]; 9. Drug Therapy, Combination; 10. Patient Preference; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Oral paracetamol (acetaminophen) for cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [adverse effects, *therapeutic use]; 2. Chlorpromazine [adverse effects, therapeutic use]; 3. Dexamethasone [adverse effects, therapeutic use]; 4. Indoles [adverse effects, therapeutic use]; 5. Metoclopramide [adverse effects, therapeutic use]; 6. Nausea [*drug therapy, etiology]; 7. Neoplasms [*complications]; 8. Time Factors; 9. Tropisetron; 10. Vomiting [*drug therapy, etiology]; | Provide MESH terms for the study
Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery) | You are a research assistant. Based on the question please provide appropriate answers |
1. Drainage [*methods]; 2. Genital Neoplasms, Female [*surgery]; 3. Lymph Node Excision [*adverse effects]; 4. Lymphocele [etiology, *prevention & control]; 5. Pelvis; 6. Randomized Controlled Trials as Topic; 7. Retroperitoneal Space; 8. Suction [methods]; | Provide MESH terms for the study
Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics [adverse effects, *therapeutic use]; 2. Analgesics, Opioid [*therapeutic use]; 3. Cancer Pain [*drug therapy]; 4. Chemotherapy, Adjuvant; 5. Hallucinations [chemically induced]; 6. Ketamine [adverse effects, *therapeutic use]; 7. Morphine [adverse effects, *therapeutic use]; 8. Palliative Care; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Ketamine as an adjuvant to opioids for cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal [*therapeutic use]; 2. Antineoplastic Agents [*therapeutic use]; 3. Bevacizumab [therapeutic use]; 4. Colorectal Neoplasms [*drug therapy, genetics, mortality, pathology]; 5. Diarrhea [chemically induced, epidemiology]; 6. Disease-Free Survival; 7. ErbB Receptors [*antagonists & inhibitors]; 8. Exanthema [chemically induced, epidemiology]; 9. Neutropenia [chemically induced, epidemiology]; 10. Protein Kinase Inhibitors [*therapeutic use]; 11. Protein-Tyrosine Kinases [*antagonists & inhibitors]; 12. Proto-Oncogene Proteins p21(ras) [genetics]; 13. Quality of Life; 14. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Alopecia [chemically induced, epidemiology]; 2. Anemia [chemically induced]; 3. Antineoplastic Combined Chemotherapy Protocols [adverse effects, *therapeutic use]; 4. Breast Neoplasms [*drug therapy, mortality, pathology]; 5. Carboplatin [administration & dosage, adverse effects]; 6. Cisplatin [administration & dosage, adverse effects]; 7. Disease-Free Survival; 8. Leukopenia [chemically induced, epidemiology]; 9. Nausea [chemically induced]; 10. Organoplatinum Compounds [administration & dosage, adverse effects]; 11. Pyridines [administration & dosage, adverse effects]; 12. Randomized Controlled Trials as Topic; 13. Survival Rate; 14. Triple Negative Breast Neoplasms [drug therapy, mortality, pathology]; 15. Vomiting [chemically induced, epidemiology]; | Provide MESH terms for the study
Platinum‐containing regimens for metastatic breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Palliative Care; 2. *Quality of Life; 3. Communication; 4. Neoplasms [pathology, *psychology, *therapy]; 5. Physician‐Patient Relations; | Provide MESH terms for the study
Early palliative care for adults with advanced cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Combined Modality Therapy [methods]; 2. Laser Therapy [*methods]; 3. Retinal Neoplasms [*drug therapy, *surgery]; 4. Retinoblastoma [*drug therapy, *surgery]; | Provide MESH terms for the study
Focal laser treatment in addition to chemotherapy for retinoblastoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [adverse effects, *therapeutic use]; 2. Febrile Neutropenia [*drug therapy, mortality]; 3. Glycopeptides [adverse effects, therapeutic use]; 4. Gram‐Positive Bacterial Infections [*drug therapy, mortality]; 5. Neoplasms [*complications]; 6. Randomized Controlled Trials as Topic; 7. Treatment Failure; | Provide MESH terms for the study
Empirical antibiotics targeting gram‐positive bacteria for the treatment of febrile neutropenic patients with cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Palliative Care; 2. Anti‐Anxiety Agents [*therapeutic use]; 3. Anxiety [*drug therapy]; 4. Terminally Ill [*psychology]; | Provide MESH terms for the study
Drug therapy for symptoms associated with anxiety in adult palliative care patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetaminophen [adverse effects, *therapeutic use]; 2. Analgesics, Non‐Narcotic [adverse effects, *therapeutic use]; 3. Analgesics, Opioid [adverse effects, *therapeutic use]; 4. Cancer Pain [*drug therapy]; 5. Drug Therapy, Combination; 6. Randomized Controlled Trials as Topic; 7. Tramadol [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Tramadol with or without paracetamol (acetaminophen) for cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [adverse effects, *therapeutic use]; 2. Bevacizumab [therapeutic use]; 3. Cancer Vaccines [therapeutic use]; 4. Carcinoma, Renal Cell [mortality, secondary, *therapy]; 5. Clinical Trials, Phase III as Topic; 6. Immunologic Factors [adverse effects, *therapeutic use]; 7. Immunotherapy [adverse effects, *methods]; 8. Indoles [therapeutic use]; 9. Interferon‐alpha [therapeutic use]; 10. Kidney Neoplasms [mortality, pathology, *therapy]; 11. Longevity [drug effects]; 12. Pyrroles [therapeutic use]; 13. Quality of Life; 14. Randomized Controlled Trials as Topic; 15. Sirolimus [analogs & derivatives, therapeutic use]; 16. Sunitinib; | Provide MESH terms for the study
Immunotherapy for metastatic renal cell carcinoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Carcinoma, Renal Cell [mortality, pathology, *surgery]; 2. Cause of Death; 3. Kidney Neoplasms [mortality, pathology, *surgery]; 4. Neoplasm Recurrence, Local [mortality]; 5. Nephrectomy [*methods, mortality]; 6. Randomized Controlled Trials as Topic; 7. Time Factors; | Provide MESH terms for the study
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses | You are a research assistant. Based on the question please provide appropriate answers |
1. *Recovery of Function; 2. Cardiovascular Diseases [etiology]; 3. Cystectomy [*adverse effects, methods]; 4. Defecation; 5. Eating; 6. Gastrointestinal Agents [adverse effects, *therapeutic use]; 7. Ileus [*drug therapy, etiology]; 8. Patient Discharge; 9. Patient Readmission; 10. Piperidines [adverse effects, *therapeutic use]; 11. Postoperative Complications [*drug therapy]; 12. Randomized Controlled Trials as Topic; 13. Time Factors; 14. Urinary Diversion [*adverse effects, methods]; | Provide MESH terms for the study
Alvimopan for recovery of bowel function after radical cystectomy | You are a research assistant. Based on the question please provide appropriate answers |
1. Biopsy [methods]; 2. Brain [*pathology]; 3. Brain Neoplasms [*pathology, *surgery]; 4. Glioma [*pathology, *surgery]; | Provide MESH terms for the study
Biopsy versus resection for the management of low‐grade gliomas | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [*administration & dosage, adverse effects]; 2. Hematopoietic Stem Cell Transplantation [*methods, mortality]; 3. Salvage Therapy [*methods, mortality]; 4. Sarcoma [*drug therapy, mortality]; 5. Transplantation, Autologous; | Provide MESH terms for the study
Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas | You are a research assistant. Based on the question please provide appropriate answers |
1. Anxiety [therapy]; 2. Breast Neoplasms [*psychology]; 3. Consumer Health Information [*statistics & numerical data]; 4. Depression [therapy]; 5. Peer Group; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Self‐Help Groups [*statistics & numerical data]; 9. Time Factors; | Provide MESH terms for the study
Online support groups for women with breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Adjuvants, Immunologic [*administration & dosage, adverse effects]; 2. Administration, Intravesical; 3. Antineoplastic Agents [*administration & dosage, adverse effects]; 4. BCG Vaccine; 5. Carcinoma in Situ [mortality, pathology, *therapy]; 6. Combined Modality Therapy [adverse effects, methods]; 7. Disease Progression; 8. Drug Administration Schedule; 9. Interferon-alpha [*administration & dosage, adverse effects]; 10. Neoplasm Recurrence, Local; 11. Randomized Controlled Trials as Topic; 12. Time Factors; 13. Urinary Bladder Neoplasms [mortality, pathology, *therapy]; 14. Withholding Treatment [statistics & numerical data]; | Provide MESH terms for the study
Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating non‐muscle‐invasive bladder cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Alanine Transaminase [blood]; 2. Bilirubin [blood]; 3. Carcinoma, Hepatocellular [enzymology, pathology, *radiotherapy]; 4. Cause of Death; 5. Chemoembolization, Therapeutic [mortality]; 6. Combined Modality Therapy [methods, mortality]; 7. Liver Neoplasms [enzymology, pathology, *radiotherapy]; 8. Radiotherapy [methods, mortality]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
External beam radiotherapy for unresectable hepatocellular carcinoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Awareness; 2. *Health Knowledge, Attitudes, Practice; 3. *Pamphlets; 4. Age Factors; 5. Breast Neoplasms [*diagnosis]; 6. Breast Self‐Examination [statistics & numerical data]; 7. Health Education [*methods, statistics & numerical data]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for raising breast cancer awareness in women | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics, Opioid [*therapeutic use]; 2. Methadone [*therapeutic use]; 3. Morphine [therapeutic use]; 4. Neoplasms [*complications]; 5. Pain [*drug therapy, etiology]; 6. Pain Measurement; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Methadone for cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*therapeutic use]; 2. Antineoplastic Combined Chemotherapy Protocols [administration & dosage, *therapeutic use]; 3. Bevacizumab [administration & dosage]; 4. Camptothecin [administration & dosage, analogs & derivatives, therapeutic use]; 5. Colorectal Neoplasms [*drug therapy, mortality, pathology]; 6. Fluorouracil [administration & dosage]; 7. Irinotecan; 8. Leucovorin [administration & dosage]; 9. Organoplatinum Compounds [administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Survival Rate; | Provide MESH terms for the study
Second‐line systemic therapy for metastatic colorectal cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Colposcopy [*statistics & numerical data]; 2. Papillomaviridae [isolation & purification]; 3. Patient Compliance [statistics & numerical data]; 4. Precancerous Conditions [*diagnosis, *pathology]; 5. Randomized Controlled Trials as Topic; 6. *Referral and Consultation; 7. Time Factors; 8. Uterine Cervical Dysplasia [*diagnosis, *pathology]; 9. Vaginal Smears [*statistics & numerical data]; 10. Watchful Waiting; | Provide MESH terms for the study
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [adverse effects, *therapeutic use]; 2. Bacterial Infections [*prevention & control]; 3. Postoperative Complications [*prevention & control]; 4. Postoperative Hemorrhage [etiology]; 5. Precancerous Conditions [*surgery]; 6. Randomized Controlled Trials as Topic; 7. Uterine Cervical Dysplasia [*surgery]; 8. Uterine Cervical Neoplasms [*surgery]; | Provide MESH terms for the study
Antibiotics for infection prevention after excision of the cervical transformation zone | You are a research assistant. Based on the question please provide appropriate answers |
1. Adenoma [*prevention & control]; 2. Adenomatous Polyps [*prevention & control]; 3. Colorectal Neoplasms [*prevention & control]; 4. Dietary Fiber [adverse effects, *therapeutic use]; 5. Neoplasm Recurrence, Local; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas | You are a research assistant. Based on the question please provide appropriate answers |
1. Axilla; 2. Breast Neoplasms [mortality, radiotherapy, *surgery]; 3. Lymph Node Excision [adverse effects, *methods]; 4. Lymphedema [etiology]; 5. Neoplasm Recurrence, Local [mortality]; 6. Randomized Controlled Trials as Topic; 7. Sentinel Lymph Node Biopsy [adverse effects, methods]; | Provide MESH terms for the study
Axillary treatment for operable primary breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Anastrozole; 2. Antineoplastic Agents, Hormonal [adverse effects, *therapeutic use]; 3. Breast Neoplasms [*drug therapy, mortality, pathology]; 4. Disease‐Free Survival; 5. Estradiol [adverse effects, *analogs & derivatives, therapeutic use]; 6. Fulvestrant; 7. Neoplasms, Hormone‐Dependent [drug therapy]; 8. Nitriles [therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Triazoles [therapeutic use]; | Provide MESH terms for the study
Fulvestrant for hormone‐sensitive metastatic breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Mental Health; 2. *Quality of Life; 3. *Yoga; 4. Anxiety [etiology, therapy]; 5. Breast Neoplasms [*complications, *psychology, therapy]; 6. Depression [etiology, therapy]; 7. Fatigue [etiology, therapy]; 8. Randomized Controlled Trials as Topic; 9. Sleep Wake Disorders [etiology, therapy]; | Provide MESH terms for the study
Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Chemoradiotherapy, Adjuvant; 2. *Robotic Surgical Procedures; 3. Carcinoma, Squamous Cell [radiotherapy, surgery, *therapy]; 4. Laser Therapy [*methods]; 5. Microsurgery [*methods]; 6. Oropharyngeal Neoplasms [pathology, radiotherapy, surgery, *therapy]; 7. Radiotherapy, Adjuvant; | Provide MESH terms for the study
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal carcinoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Nipples; 2. Breast Neoplasms [mortality, *surgery]; 3. Carcinoma, Intraductal, Noninfiltrating [mortality, *surgery]; 4. Cohort Studies; 5. Mastectomy [adverse effects, *methods, mortality]; 6. Neoplasm Recurrence, Local; 7. Organ Sparing Treatments [adverse effects, *methods]; 8. Postoperative Complications; 9. Skin; | Provide MESH terms for the study
Nipple‐ and areola‐sparing mastectomy for the treatment of breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. Anxiety [therapy]; 3. Fatigue [*etiology, *therapy]; 4. Neoplasms [*complications, therapy]; 5. Patient Education as Topic [*methods]; 6. Problem Solving; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Reinforcement, Psychology; | Provide MESH terms for the study
Educational interventions for the management of cancer‐related fatigue in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; 2. Chemotherapy, Adjuvant [methods]; 3. Cisplatin [administration & dosage]; 4. Fluorouracil [administration & dosage]; 5. Hysterectomy; 6. Neoplasm Staging; 7. Platinum Compounds [*therapeutic use]; 8. Radiotherapy, Adjuvant; 9. Randomized Controlled Trials as Topic; 10. Survival Analysis; 11. Uterine Cervical Neoplasms [*drug therapy, pathology, radiotherapy, surgery]; | Provide MESH terms for the study
Adjuvant platinum‐based chemotherapy for early stage cervical cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Benzodiazepines [adverse effects, *therapeutic use]; 2. Dyspnea [*drug therapy, etiology]; 3. Lung Neoplasms [*complications]; 4. Pulmonary Disease, Chronic Obstructive [*complications]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. Disease Progression; 3. Heart Failure [complications]; 4. Leg; 5. Muscle Strength; 6. Muscle Weakness [etiology, *therapy]; 7. Muscle, Skeletal [anatomy & histology]; 8. Physical Exertion [physiology]; 9. Pulmonary Disease, Chronic Obstructive [complications]; 10. Quadriceps Muscle [physiology]; 11. Randomized Controlled Trials as Topic; 12. Respiration Disorders [complications]; 13. Thoracic Neoplasms [complications]; 14. Transcutaneous Electric Nerve Stimulation [adverse effects, *methods]; | Provide MESH terms for the study
Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Early Detection of Cancer [*methods]; 2. *Laparoscopy; 3. *Laparotomy; 4. Neoplasm Staging; 5. Ovarian Neoplasms [pathology, *surgery]; | Provide MESH terms for the study
Laparoscopy versus laparotomy for FIGO stage I ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise Therapy; 2. Breast Neoplasms [psychology, *therapy]; 3. Chemotherapy, Adjuvant [adverse effects]; 4. Cognition; 5. Depression [therapy]; 6. Fatigue [rehabilitation]; 7. Lymphedema [etiology]; 8. Physical Fitness; 9. Quality of Life; 10. Radiotherapy, Adjuvant [adverse effects]; 11. Randomized Controlled Trials as Topic; 12. Weight Gain; | Provide MESH terms for the study
Exercise for women receiving adjuvant therapy for breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Deglutition; 2. *Myofunctional Therapy; 3. Chemoradiotherapy; 4. Deglutition Disorders [etiology, *therapy]; 5. Head and Neck Neoplasms [pathology, *therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Therapeutic exercises for affecting post‐treatment swallowing in people treated for advanced‐stage head and neck cancers | You are a research assistant. Based on the question please provide appropriate answers |
1. Bone Density; 2. Calcium, Dietary [*administration & dosage]; 3. Cardiovascular Diseases [prevention & control]; 4. Endocrine System Diseases [prevention & control]; 5. Fast Foods; 6. *Health Behavior; 7. Intention to Treat Analysis; 8. Metabolic Syndrome [prevention & control]; 9. Milk; 10. *Neoplasms [therapy]; 11. Nutrition Therapy [*methods]; 12. Osteoporosis [prevention & control]; 13. Precursor Cell Lymphoblastic Leukemia-Lymphoma [therapy]; 14. Randomized Controlled Trials as Topic; 15. *Survivors; 16. Vitamin D [*administration & dosage]; 17. Vitamins [*administration & dosage]; | Provide MESH terms for the study
Nutritional interventions for survivors of childhood cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Breast Neoplasms [*therapy]; 2. Cognition [physiology]; 3. Cognition Disorders [etiology, *therapy]; 4. Exercise; 5. Meditation [methods]; 6. Memory; 7. Mental Health; 8. Neoplasms [therapy]; 9. Randomized Controlled Trials as Topic; 10. Survivors; 11. Therapy, Computer-Assisted [methods]; | Provide MESH terms for the study
Non‐pharmacological interventions for cognitive impairment due to systemic cancer treatment | You are a research assistant. Based on the question please provide appropriate answers |
1. Leukoplakia, Oral [*therapy]; 2. Mouth Neoplasms [*prevention & control]; 3. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for treating oral leukoplakia to prevent oral cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Australia; 2. Carcinoma, Basal Cell [*prevention & control]; 3. Carcinoma, Squamous Cell [*prevention & control]; 4. Neoplasms, Radiation‐Induced [*prevention & control]; 5. Randomized Controlled Trials as Topic; 6. Skin Neoplasms [*prevention & control]; 7. Sunlight [*adverse effects]; 8. Sunscreening Agents [*administration & dosage, adverse effects]; 9. Ultraviolet Rays [adverse effects]; 10. Vitamins [administration & dosage, adverse effects]; 11. beta Carotene [administration & dosage, adverse effects]; | Provide MESH terms for the study
Sun protection for preventing basal cell and squamous cell skin cancers | You are a research assistant. Based on the question please provide appropriate answers |
1. Adenocarcinoma [*drug therapy, mortality, pathology]; 2. Angiogenesis Inhibitors [therapeutic use]; 3. Disease-Free Survival; 4. ErbB Receptors [antagonists & inhibitors]; 5. Esophageal Neoplasms [*drug therapy, mortality, pathology]; 6. *Esophagogastric Junction; 7. Molecular Targeted Therapy [adverse effects, *methods]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Receptor, ErbB-2 [antagonists & inhibitors]; 11. Stomach Neoplasms [*drug therapy, mortality, pathology]; | Provide MESH terms for the study
Molecular‐targeted first‐line therapy for advanced gastric cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Analgesics [*administration & dosage]; 3. Colposcopy [*adverse effects]; 4. Drug Therapy, Combination [methods]; 5. Intraoperative Complications [*therapy]; 6. Pain Management [*methods]; 7. Pain Measurement; 8. Pain, Postoperative [*therapy]; 9. Randomized Controlled Trials as Topic; 10. Transcutaneous Electric Nerve Stimulation [methods]; 11. Uterine Cervical Dysplasia [*surgery]; 12. Uterine Cervical Neoplasms [*surgery]; | Provide MESH terms for the study
Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment | You are a research assistant. Based on the question please provide appropriate answers |
1. *Radiation Dose Hypofractionation; 2. Breast Neoplasms [*radiotherapy, surgery]; 3. Combined Modality Therapy [methods]; 4. Dose Fractionation, Radiation; 5. Mastectomy, Segmental; 6. Radiation Injuries [complications, mortality]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Hypofractionated radiation therapy for early breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibiotics, Antineoplastic [*administration & dosage]; 2. Bleomycin [*administration & dosage]; 3. Craniopharyngioma [*drug therapy]; 4. Cysts [*drug therapy]; 5. Injections, Intralesional [methods]; 6. Phosphorus Radioisotopes [administration & dosage]; 7. Pituitary Neoplasms [*drug therapy]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intracystic bleomycin for cystic craniopharyngiomas in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents, Alkylating [*therapeutic use]; 2. Antineoplastic Agents, Hormonal [*therapeutic use]; 3. Busulfan [*analogs & derivatives, therapeutic use]; 4. Carcinoma, Ovarian Epithelial; 5. Gonadotropin-Releasing Hormone [*agonists]; 6. Leuprolide [*therapeutic use]; 7. Neoplasm Recurrence, Local [*drug therapy]; 8. Neoplasms, Glandular and Epithelial [*drug therapy]; 9. Ovarian Neoplasms [*drug therapy]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Brain Stem; 2. *Dose Fractionation, Radiation; 3. Brain Neoplasms [mortality, pathology, *radiotherapy]; 4. Glioma [mortality, pathology, *radiotherapy]; 5. Neoplasm Invasiveness; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Radiotherapy for diffuse brainstem glioma in children and young adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Aromatherapy; 2. Affect; 3. Anxiety [*therapy]; 4. Breast Neoplasms [complications]; 5. Depression [*therapy]; 6. Fatigue [therapy]; 7. Massage [*methods]; 8. Neoplasms [*complications, psychology]; 9. Pain Management [*methods]; 10. Plant Oils [therapeutic use]; | Provide MESH terms for the study
Massage with or without aromatherapy for symptom relief in people with cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Breast Neoplasms [*diagnosis, mortality, pathology, *therapy]; 2. Follow‐Up Studies; 3. General Practice; 4. Mammography; 5. Medical Oncology; 6. Neoplasm Recurrence, Local [*diagnosis, mortality]; 7. Neoplasm Staging; 8. Physical Examination; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Follow‐up strategies for women treated for early breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bone Marrow Transplantation; 2. *Stem Cell Transplantation; 3. Antineoplastic Agents [*administration & dosage, adverse effects]; 4. Antineoplastic Combined Chemotherapy Protocols [*administration & dosage, adverse effects]; 5. Breast Neoplasms [*drug therapy, mortality, *surgery]; 6. Combined Modality Therapy [methods]; 7. Prognosis; 8. Randomized Controlled Trials as Topic; 9. Salvage Therapy; 10. Survival Rate; 11. Time Factors; 12. Transplantation, Autologous; | Provide MESH terms for the study
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Mammaplasty; 2. Breast Implants [*classification]; 3. Breast Neoplasms [*surgery]; 4. Hydrogels; 5. Mastectomy; 6. Patient Satisfaction; 7. Prophylactic Surgical Procedures; 8. Prosthesis Failure; 9. Randomized Controlled Trials as Topic; 10. Silicone Gels; 11. Sodium Chloride; | Provide MESH terms for the study
Different types of implants for reconstructive breast surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Hospital Mortality; 2. Pancreatic Fistula [*prevention & control]; 3. Pancreaticoduodenectomy [*adverse effects]; 4. Randomized Controlled Trials as Topic; 5. Reoperation; 6. Stents [*classification]; 7. Time Factors; 8. Treatment Outcome; | Provide MESH terms for the study
Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Inflammatory Agents [therapeutic use]; 2. Electrocoagulation [methods]; 3. Fatty Acids [therapeutic use]; 4. Formaldehyde [therapeutic use]; 5. Hyperbaric Oxygenation; 6. Pelvic Neoplasms [radiotherapy]; 7. Proctitis [*therapy]; 8. Radiation Injuries [*therapy]; 9. Randomized Controlled Trials as Topic; 10. Rectum [*radiation effects]; 11. Sucralfate [therapeutic use]; | Provide MESH terms for the study
Non‐surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. Antifungal Agents [therapeutic use]; 3. Antineoplastic Agents [*adverse effects]; 4. Bacterial Infections [*prevention & control]; 5. Fever [diet therapy]; 6. Mycoses [*prevention & control]; 7. Neoplasms [*drug therapy]; 8. Neutropenia [chemically induced, *diet therapy]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Analgesics, Opioid [*administration & dosage]; 3. Morphine [*administration & dosage]; 4. Neoplasms [*complications]; 5. Pain [*drug therapy, radiotherapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Oral morphine for cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. *Indicators and Reagents; 2. *Indigo Carmine; 3. Colonic Polyps [diagnosis]; 4. Colonoscopy [*methods]; 5. Intestinal Polyps [*diagnosis]; 6. Precancerous Conditions [diagnosis]; 7. Randomized Controlled Trials as Topic; 8. Rectal Diseases [*diagnosis]; | Provide MESH terms for the study
Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [immunology, *therapeutic use]; 2. Immunity, Cellular [immunology]; 3. Neoplasms [*drug therapy, immunology, therapy]; 4. Randomized Controlled Trials as Topic; 5. Reishi [*chemistry]; | Provide MESH terms for the study
Ganoderma lucidum (Reishi mushroom) for cancer treatment | You are a research assistant. Based on the question please provide appropriate answers |
1. *Laparoscopy [adverse effects, mortality]; 2. Case‐Control Studies; 3. Pancreatectomy [adverse effects, *methods, mortality]; 4. Pancreatic Neoplasms [*surgery]; 5. Retrospective Studies; | Provide MESH terms for the study
Laparoscopic versus open distal pancreatectomy for pancreatic cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Gastrectomy [adverse effects, *methods, mortality]; 2. Laparoscopy [adverse effects, *methods, mortality]; 3. Stomach Neoplasms [mortality, *surgery]; | Provide MESH terms for the study
Laparoscopic versus open gastrectomy for gastric cancer | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.